US 11,807,621 B2
Compounds and compositions for use in treating skin disorders
Xinyuan Wu, Newton, MA (US); Bertrand L. Chenard, Waterford, CT (US); Nili Claudia Schutz, Ness Ziona (IL); and Dov Terkieltaub, Herzliya (IL)
Assigned to KAMARI PHARMA LTD., Ness Ziona (IL)
Filed by KAMARI PHARMA LTD., Herzliya (IL)
Filed on Jan. 28, 2021, as Appl. No. 17/160,802.
Claims priority of provisional application 62/967,500, filed on Jan. 29, 2020.
Prior Publication US 2022/0332697 A1, Oct. 20, 2022
Int. Cl. C07D 401/12 (2006.01); A61P 17/12 (2006.01); C07D 401/04 (2006.01); C07D 401/06 (2006.01); C07D 401/14 (2006.01); C07D 403/06 (2006.01); C07D 405/12 (2006.01); C07D 405/14 (2006.01); C07D 417/06 (2006.01); C07D 417/12 (2006.01); C07D 417/14 (2006.01)
CPC C07D 401/12 (2013.01) [A61P 17/12 (2018.01); C07D 401/04 (2013.01); C07D 401/06 (2013.01); C07D 401/14 (2013.01); C07D 403/06 (2013.01); C07D 405/12 (2013.01); C07D 405/14 (2013.01); C07D 417/06 (2013.01); C07D 417/12 (2013.01); C07D 417/14 (2013.01)] 27 Claims
 
1. A compound selected from

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry
or a stereoisomer, racemate or pharmaceutically acceptable salt thereof.